US rare disease specialist Sentynl Therapeutics, owned by India’s Zydus Lifesciences (NSE: ZYDUSLIFE), says the US regulator ...

UK-based Qureight, a tech-bio company advancing the understanding of lung and heart disease through application of its ...

Germany’s Merck KGaA has announced that the US Food and Drug Administration (FDA) has accepted the company’s new drug ...

Hong Kong-listed Sino Biopharmaceutical (HKEX: 1177) is to buy fellow Chinese firm Hangzhou Hygieia Biomedical (HKEX: 6078) ...

The Biotechnology Innovation Organization criticized changes to the US childhood immunization schedule, saying the move lacks ...

US pharma major AbbVie (NYSE: ABBV) plans to acquire a drug delivery device manufacturing facility in Tempe, Arizona, as part ...

Efforts to return to growth in UK clinical trials are gathering pace, with new figures showing a sharp rise in activity in ...

Taiwan-based PharmaEssentia Corporation, a biopharma seeking to deliver new biologics in hematology and oncology, has announced that the US Food and Drug Administration (FDA) has accepted the ...

The European Academy of Allergy and Clinical Immunology’s flagship annual meeting, bringing together the global allergy, ...

The Endocrine Society’s flagship annual meeting, bringing together the global endocrinology community to share cutting-edge ...

An Oxford Global event designed to connect stakeholders across early-stage R&D—from target discovery and lead optimisation ...

A specialist meeting for drug safety and pharmacovigilance professionals focused on strengthening patient safety and ...